Outer membrane vesicles from group B meningococci are strongly immunogenic when given intranasally to mice.
Outer membrane vesicles (OMVs) from group B meningococci induced both serum and mucosal antibodies when given as a nasal and rectal vaccine to mice. Cholera toxin (CT) enhanced the antibody responses in serum both after nasal and rectal immunizations, and the mucosal responses after rectal immunizations only. Nasal immunizations, however, were most effective, with mucosal responses which were not dependent on the use of CT. The serum bactericidal activity was similarly not enhanced by CT, indicating that the positive effect of CT on the serum IgG level was not including bactericidal activity. A small nasal booster dose induced antibody responses in serum as far as eight months after intranasal and subcutaneous immunizations, and in saliva after intranasal immunizations. Nasal vaccines may thus be favorably combined with parenteral vaccines.
Department of Vaccinology, National Institute of Public Health, Oslo, Norway. rdalseg@embnet.uio.no
R
R
Dalseg
E
E
Wedege
J
J
Holst
I L
IL
Haugen
E A
EA
Høiby
B
B
Haneberg
D000281:Administration, Intranasal; D000818:Animals; D000907:Antibodies, Bacterial / Q000032:analysis; D016667:Bacterial Capsules; D001770:Blood Bactericidal Activity; D002772:Cholera Toxin / Q000494:pharmacology; D004306:Dose-Response Relationship, Immunologic; D005260:Female; D018928:Immunity, Mucosal; D007156:Immunologic Memory; D051379:Mice; D008807:Mice, Inbred BALB C; D009345:Neisseria meningitidis / Q000737:chemistry / Q000276:immunology*; D011135:Polysaccharides, Bacterial / Q000008:administration & dosage / Q000276:immunology*
D000907:Antibodies, Bacterial; D011135:Polysaccharides, Bacterial; C039455:capsular polysaccharide, meningococcal group B; D002772:Cholera Toxin